Inovio Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -1.01%
- Market cap
- $274.40M
- 187.31M shares
- Filings
- 1,026
Q3 2026−70.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−32.7% FY25 yoy
- $274.40M
- —
- 918.0×
- —
- -27.12%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65,343 | reported | |
| FY 2024 | 2024-12-31 | $217,756 | reported | |
| FY 2023 | 2023-12-31 | $832,010 | reported | |
| FY 2022 | 2022-12-31 | $10,262,268 | reported | |
| FY 2021 | 2021-12-31 | $1,774,758 | reported | |
| FY 2020 | 2020-12-31 | $7,411,220 | reported | |
| FY 2019 | 2019-12-31 | $4,111,930 | reported | |
| FY 2018 | 2018-12-31 | $30,481,897 | reported | |
| FY 2017 | 2017-12-31 | $42,220,086 | reported | |
| FY 2016 | 2016-12-31 | $35,368,361 | reported | |
| FY 2015 | 2015-12-31 | $40,572,111 | reported | |
| FY 2014 | 2014-12-31 | $10,456,766 | reported |
Segments
Products
LineFY2021ShareChange
Revenue under collaborative research and development arrangements$902.26K51%−82.6%
Other revenue$627.19K35%−20.3%
Revenue under collaborative research and development arrangements from affiliated entities$245.31K14%−83.1%
Other revenue from affiliated entities$0.00——
Total$1.77M
Pharmaceutical preparations
Inovio Pharmaceuticals, Inc. is the 245th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IBIOiBio, Inc.$100.0K75.0%33,044.0%$53.9MATNMActinium Pharmaceuticals, Inc.$90.0K—37,652.2%$44.8MSILOSilo Pharma, Inc.$72.1K0.0%5,863.5%$3.0M
INOInovio Pharmaceuticals, Inc. (this company)$65.3K70.0%130,000.0%$274.4M
CNTBConnect Biopharma Holdings Ltd$64.0K99.8%86,687.5%$42.0MAVTXAvalo Therapeutics, Inc.$59.0K86.6%132,642.4%$444.4MHCWBHCW Biologics Inc.$54.2K97.9%14,677.1%$1.6MALTAltimmune, Inc.$41.0K105.0%214,861.0%$312.3MNTHINeonc Technologies Holdings, Inc.$40.0K51.8%155,404.4%$139.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR